- Home
- KVHI vs HLVX Comparison
KVHI vs HLVX Comparison
Compare KVHI & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- HLVX
- Stock Information
- Founded
- KVHI 1978
- HLVX 2020
- Country
- KVHI United States
- HLVX United States
- Employees
- KVHI N/A
- HLVX N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- KVHI Technology
- HLVX Health Care
- Exchange
- KVHI Nasdaq
- HLVX Nasdaq
- Market Cap
- KVHI 101.5M
- HLVX 105.2M
- IPO Year
- KVHI 1996
- HLVX 2022
- Fundamental
- Price
- KVHI $5.28
- HLVX $2.15
- Analyst Decision
- KVHI
- HLVX Hold
- Analyst Count
- KVHI 0
- HLVX 1
- Target Price
- KVHI N/A
- HLVX $2.00
- AVG Volume (30 Days)
- KVHI 28.4K
- HLVX 364.7K
- Earning Date
- KVHI 08-04-2025
- HLVX 08-07-2025
- Dividend Yield
- KVHI N/A
- HLVX N/A
- EPS Growth
- KVHI N/A
- HLVX N/A
- EPS
- KVHI N/A
- HLVX N/A
- Revenue
- KVHI $109,975,000.00
- HLVX N/A
- Revenue This Year
- KVHI $1.02
- HLVX N/A
- Revenue Next Year
- KVHI $12.63
- HLVX N/A
- P/E Ratio
- KVHI N/A
- HLVX N/A
- Revenue Growth
- KVHI N/A
- HLVX N/A
- 52 Week Low
- KVHI $4.17
- HLVX $1.34
- 52 Week High
- KVHI $6.16
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- KVHI 47.43
- HLVX 61.80
- Support Level
- KVHI $5.25
- HLVX $2.07
- Resistance Level
- KVHI $5.47
- HLVX $2.16
- Average True Range (ATR)
- KVHI 0.16
- HLVX 0.07
- MACD
- KVHI -0.01
- HLVX -0.00
- Stochastic Oscillator
- KVHI 23.26
- HLVX 89.47
About KVHI KVH Industries Inc.
KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.